AZMCF
Next report

Nov 12 2026in 48 days

EPS estimate

($0.01)

Revenue estimate

—

EPS beats

8 of last 11

EPS surprise

2023: 12.4%2024: -3.7%2024: -26.5%2024: 0.0%2025: -12.5%2025: 5.6%2025: 23.1%2025: 25.0%2026: 4.6%2026: 42.8%2026: 66.7%
Nov 14 2023Aug 6 2026
ReportedEPS estEPS actualSurpriseRevenue estRevenue actualSurprise
Aug 6 2026($0.02)($0.01)+66.7%———
May 14 2026($0.03)($0.01)+42.8%———
Mar 26 2026($0.03)($0.03)+4.6%———
Nov 13 2025($0.03)($0.02)+25.0%———
Aug 4 2025($0.03)($0.02)+23.1%———
May 14 2025($0.03)($0.02)+5.6%———
Mar 27 2025($0.03)($0.03)-12.5%———
Nov 14 2024($0.04)($0.04)+0.0%———
Aug 8 2024($0.03)($0.04)-26.5%———
May 15 2024($0.04)($0.04)-3.7%———
Apr 30 2024—($0.06)————
Nov 14 2023($0.04)($0.03)+12.4%———

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev—
EPS—
FY2028
Rev—
EPS—
FY2029
Rev—
EPS—
Raw consensus estimates (low / average / high) from covering analysts.
Annual
MetricFY2026EFY2027EFY2028EFY2029E
Revenue Avg————
Low————
High————
EBITDA Avg————
Low————
High————
EBIT Avg————
Low————
High————
Net Income Avg$-10M$-12M$-12M$-3M
Low$-10M$-12M$-12M$-3M
High$-10M$-12M$-12M$-3M
EPS Avg$-0.07$-0.09$-0.09$-0.02
Low$-0.07$-0.09$-0.09$-0.02
High$-0.07$-0.09$-0.09$-0.02
Analysts (Rev / EPS)— / 1— / 1— / 1— / 1
Quarterly
MetricQ3 2026Q4 2026Q1 2027Q2 2027Q3 2027Q4 2027Q1 2028Q2 2028
Revenue Avg————————
Low————————
High————————
EBITDA Avg————————
Low————————
High————————
EBIT Avg————————
Low————————
High————————
Net Income Avg$-3M$-3M$-1M$-1M$-4M$-4M$-3M$-3M
Low$-3M$-3M$-1M$-1M$-4M$-4M$-3M$-3M
High$-3M$-3M$-1M$-1M$-4M$-4M$-3M$-3M
EPS Avg$-0.02$-0.02$-0.01$-0.01$-0.03$-0.03$-0.02$-0.02
Low$-0.02$-0.02$-0.01$-0.01$-0.03$-0.03$-0.02$-0.02
High$-0.02$-0.02$-0.01$-0.01$-0.03$-0.03$-0.02$-0.02
Analysts (Rev / EPS)— / 1— / 1— / 1— / 1— / 1— / 1— / 1— / 1

Earnings Call Transcripts

No earnings transcripts available for AZMCF

Transcripts may not be available for all companies

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.